By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter reported after the close of the market Wednesday that its third-quarter revenues increased 9 percent, with a decline in its Life Sciences segment offset by growth in the Clinical Diagnostics segment.

The Orange County, Calif.-based firm brought in total revenues of $893.8 million for the three-month period ended Sept. 30, compared to $822.8 million for the third quarter of 2009. Beckman beat analysts' consensus estimate of $884.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.